CD3 signal transducing proteins are thought to be expressed on the surface of T cells only as part of clonotypic T call receptor (TCK) complexes. Contrary to this paradigm, the present study describes surface expression of CD3 proteins independently of donotypic TCR complexes, but only on immature thymocytes. Such novel donotype-independent CD3 (CIC) complexes are composed primarily of CD37e and secondarily of CD38e heterodimers that are independent of one another and are expressed on the cell surface in association with an unknown 90-100 kD protein termed CD3-associated protein (CD3AP). CIC complexes are expressed in normal mice on early thymocytes through the CD4+CD8 + stage of development, but not on mature peripheral T calls. Furthermore, CIC complexes are expressed by both TCR-severe combined immunodeficiency (SCID) thymocytes and thymoma cell lines, in the absence of any clonotypic chains. The isolation and biochemical characterization of surface CIC complexes provides a structural basis for the signaling effects of anti-CD3e antibody treatment in early thymocyte development.
T
he ability of the TCR complex to transduce signals after specific recognition of antigen resides in the invariant TCR-~" and CD3 subunits (1) (2) (3) . The CD3 subunits are only expressed on the surface of mature T cells in association with clonotypic chains of the TCR complex, but this has not been carefully examined for thymocytes early in development. Immature precursor cells enter the thymus as CD4-CD8-TCR-cells that are induced in the thymic microenvironment to enter the CD4/CD8 developmental pathway (4) . However, thyrnocytes from mice that fail to rearrange the TCR-B gene locus fail to enter the CD4/CD8 developmental pathway and are arrested at the CD4-CD8-stage (5) (6) (7) (8) (9) (10) . This developmental arrest can be overcome by treatment with anti-CD3e mAbs which signal their differentiation into CD4+CD8 + cells (11, 12) . Treatment with anti-CD3e mAb has also been found to accelerate the differentiation of normal CD4-CD8-thymocytes into CD4+CD8 + cells (13) . These functional data suggest that immature CD4-CD8-thymocytes do express on their cell surfaces CD3 components that are independent of donotypic TCR chains and that are capable of transducing signals regulating thymic maturation. In this study, we provide a structural explanation for the effects of anti-CD3e treatment on thymic maturation. We biochemically characterize a surface CD3 complex composed of independent CD3ye and CD3~ heterodimers that are expressed separately from donotypic TCR complexes on early fetal thymocytes through the CD4 + CD8 + stage of maturation, but that are extinguished on mature peripheral T cells. Furthermore, we report that such CIC complexes are also expressed by TCR-SCID thymocytes and TCRthymoma lines.
Cell Preparation and Culture. CD4+CD8 + thymocytes and splenic T cells from young adult C57BL/6 mice were prepared as described (24) . Pools of thymocytes from adult CB17 scid/scid (SCID) mice were screened for the lack of CD4 and CD8 expression by flow cytometry as described (25) .
Flow Cytoraetry. 106 CD4-CD8-SCID thymocytes were washed in staining buffer (0.1% BSA and 0.1% NaN3 in HBSS lacking phenol red) and then treated for 1 h at 4~ with either staining buffer alone, 2/~g anti-CD3~ (145-2Cll), or 2 ltg anti-TCR-~. After three washes in staining buffer, cells were stained with fluoresceinated anti-CD3~ (145-2Cll) for 1 h at 4~ washed three more times, and analyzed on a FACStar Plus | (Becton Dickinson & Co., Mountain View, CA) using three decade logarithmic amplification.
Radiolabelin,~ Immunoprecipitation, and Electrophoresis. Where spedfied cells were treated with water soluble Bolton Hunter reagent (Pierce Chemical Co., Rockford, IL) and then iodinated with lactoperoxidase as described (26) (27) (28) . Bolton Hunter reagent derivatizes both lysine residues and NH2 termini of cell surface proteins with a structure that can then be radiolabeled with 12sI (26) . Surface-labded cells were extracted at 4~ using lysis buffer (1% digitonin/0.15 M NaC1/150 mM Tris, pH 7.4), immunoprecipitated, and electrophoresed under reducing conditions as described (27) . Immune complexes to be resolved by nonequilibrium pH gradient electrophoresis (NEPHGE) were duted in NEPHGE sample buffer for 1 h at 37~ then resolved by NEPHGE foUowed by SDS-PAGE, as described (29) . Gels were fluorographed using DMSO/2, 5-diphenyloxazole (PPO) (DuPont NEN, Boston, MA) by incubating two times for 1 h each in DMSO, followed by 2 h in 20% wt/vol PPO/DMSO, and 1 h in HzO. After drying the gels were visualized either autoradiography at -70~ or by phosphoimagery, as indicated.
Ricin Fractionation. Digitonin extracts of 12sI surface-labeled CD4 + CD8 + thymocytes were fractionated using ricin-Sepharose as described (30) . Briefly, extracts were incubated with ricin beads for 16 h at 4~ after which the beads were washed three times (lysis buffer containing 0.2% digitonin) and eluted for 4 h at 4~ with 200 mM 13-lactose in wash buffer containing 0.5% digitonin.
Results
The present study was undertaken to determine if CD3 components were only expressed on the surface of T cells as part of clonotypic TCR complexes or whether they were also expressed on the surface of T cells independently of clonotypic TCR complexes. If CD3 signaling proteins were only expressed on T cells as components of TCR-o~/~ complexes, mAbs directed against CD3~ and TCR-I3 proteins should immunoprecipitate identical surface complexes. Consequently, we compared the molecular composition of surface complexes immunoprecipitated by anti-CD3e and anti-TCR-~ mAbs by SDS-PAGE under reducing conditions (Fig. 1 A) . 12sI-labeled surface complexes immunoprecipitated from mature spleen T cells by anti-CD3E and anti-TCR-13 mAbs were essentially identical. In contrast, l~I-labded surface complexes immunoprecipitated from immature CD4 +CD8 + thymocytes by anti-CD3E mAbs contained four to fivefold more labded CD33' protein than surface complexes immunoprecipitated by anti-TCRq3 mAbs (Fig. 1 A) . To examine these surface complexes with greater resolution, we analyzed anti-CD3~ and anti-TCR-B immunoprecipitates by two-dimensional NEPHGE/SDS-PAGE (Fig. 1 B) . Anti-CD3e and anti-TCK-B immunoprecipitates from mature spleen T cells contained identical surface complexes ( Fig. 1 B, righO; however, this was not the case for immunopredpitates from immature CD4 +CD8 + thymocytes ( Fig. 1 B,/eft). Anti-CD3e immunorecipitates from detergent extracts of CD4+CD8 + thymocytes not only contained all of the subunits immunoprecipitated by anti-TCR-~, but also contained a large amount of surface CD3"y protein with a basic isoelectric point (pI) that was not present in anti-TCR-13 immunoprecipitates and that was not present on spleen T cells (Fig. 1 B) . This form of CD37, was physically independent of donotypic TCR-c~/13 complexes on immature CD4 + CD8 + thymocytes as it was captured from the supematant of anti-TCR-~ immunoprecipirations by anti-CD3~ mAb, indicating association with CD3~
but not TCR-13 chains ( Fig. 1 B, bottom left) . Indeed, preclearing of donotypic TCR-c~/13 complex~ by anti-TCR-13 mAb and sequential immunopredpitation with anti-CD3e mAb ( Fig. 1 B, bottom left) revealed surface complexes that contained: (a) CD3~ chains; (b) significant amounts of CD33, protein with basic pI; and (c) small amounts of CD3/~; but did not contain donotypic TCR-a, TCR-B, or invariant TCR-~" chains. To more precisely analyze the composition of these TCR-independent CD3 complexes, we performed additional immunopredpitation experiments (l~ig. 1 C). Clonotypic TCR complexes were first removed by immunoprecipitation with anti-TCR-~ mAb, and remaining surface CD3 subunits precipitated with antibodies specific for CD3E, CD33'E, CD3/~, and TCR-~" proteins. Surface CD38 and CD33, proteins that remained after removal of donotypic TCR complexes existed as independent CD3ge and CD33,e heterodimers that were individually immunoprecipitated by either anti-CD3/~ or anti-CD33,e antibodies ( Fig. 1 C, right) .
Furthermore, these CD3 complexes were not associated with TCR-~" chains as they were not immunoprecipitated by anti-TCR-~" antibody ( Fig. 1 C, bottom right) . Thus, immature CD4+CD8 + thymocytes, but not mature spleen T cells, express surface CD3 proteins that are not part of clonotypic TCR-a/13 complexes. We refer to these TCR-independent surface comples~ as clonotype-independent CD3 (CIC) complexes, which consist primarily of CD37E and secondarily of CD3~ heterodimers, and which account for 70-90% of the labeled CD33, that is detected on the surface of immature CD4 + CD8 + thymocytes.
It is unlikely that CIC complexes result from dissociation of intact TCR-c~/13 complexes by anti-TCR-B mAbs because: (a) appearance of CIC complexes was restricted to immature thymocytes and not mature T cells, and (b) because CD33, chains in CIC complexes had a pI that was distinct from the more acidic pI of CD37' chains in clonotypic TCR-a/~ complexes. Nevertheless, we wished to detect CIC complexes on the surface of immature CD4 + CD8 + thymocytes without anti-TCR-B immunoprecipitations. Because the basic pI of CD33, chains in CIC complexes suggested incompletely processed N-linked sugars that lacked sialic acid and possibly galactose, we used an affinity matrix of the galactose-binding lectin Ricin communis agglutinin (31, 32) in an attempt to physically separate surface donotypic TCR-a/13 complexes from CIC complexes. Indeed, fractionation of cell lysates into ricin-bound and ricin-unbound fractions revealed that all surface TCR-c~/~/complexes were contained within the ricinbound fraction whereas all CIC complexes were contained within the ricin-unbound fraction (Fig. 2 A) . The lack of ricin binding of CIC complexes demonstrates that they are biochemically distinct from TCR-a/fl complexes expressed by CD4 + CD8 + thymocytes. Thus, these data demonstrate that CIC complexes are expressed on the surface of immature CD4 +CD8 + thymocytes in a form that is physically distinct from the clonotypic TCR-alfl surface complexes.
Since the N-linked glycans of CIC complexes were immature, we verified that the surface labeling was indeed restricted to cell surface proteins as proteins known to be exclusively intracellular (i.e., ribophorin I, ribophorin II, tubulin, and p56 l~k) were not 12SI-labeled (data not shown).
Since CIC complexes were physically distinct from clonotypic TCR-ol/fl complexes on CD4+CD8 + thymocytes that expressed both complexes, we asked if CIC complexes could be expressed on immature thymocytes that did not express donotypic TCR complexes. Thymocytes from SCID mice are unable to productively rearrange genes encoding clonotypic TCR chains and so are arrested at the CD4- Figure 2 . The CIC complores are biochemicaUy distinct from TCRc~/fl complexes. Digitonin e~tracts of Bolton Hunter-treated 12SI-suffacelabeled CD4 + CD8 + thymocytes were fractionated using ricin-Sepharose. Both the ricin-bound and ricin-unbound fractions were immunoprecipitated with anti-CD3e (145-2Cll), after which the immune complexes were resolved on two-dimensional gels (NEPHGE x SDS-PAGE). Positions of TCR components are indicated. The position of the basic form of CD3"y is indicated by arrows. The migration of CD3c5 is indicated by arrowheads.
1378
CD8 -TCR-stage of development (5) (6) (7) (8) . We asked if these TCR-SCID thymocytes expressed CIC complexes. Flow cytometric analysis of SCID thymocytes revealed a very low level of surface CD3e protein whose staining could be specifically blocked by unlabeled anti-CD3e mAb, but not by unlabeled anti-TCR-fl mAb (Fig. 3 A) , demonstrating that immature SCID thymocytes do express low levels of surface CIC complexes. To investigate the composition of the CD3 complexes expressed by the SCID thymocytes, surface-labeled SCID thymocytes were analyzed by immunoprecipitation. Consistent with the absence of donotypic TCR complexes, anti-TCR-fl mAb failed to specifically immunoprecipitate any surface labeled proteins from SCID thymocytes (Fig. 3 B,  left) . The faint bands that were present in some SCID anti-TCR-B immunoprecipitations were also nonspecitically precipitated by NKS (Fig. 3 B,/eft) . Interestingly, however, immunoprecipitation of surface labeled proteins with anti-CD3e mAb revealed CIC complexes on the surface of TCR-SCID thymocytes that included CD3%6, and e chains. The presence of both CD36 and CD3e proteins in the 25-kD band of experiment 2 ( Fig. 3 B,/eft) was confirmed by NEPHGE analysis (data not shown). In addition to these CD3 components, we also observed an unknown associated protein of 90-100 kD that we have termed CD3-associated protein (CD3AP). CD3AP contains no N-linked glycam (data not shown) and its further characterization is currently in progress. We then examined early (day 16) fetal thymocytes from normal mice for surface expression of CIC complexes. Although these early fetal thymocytes expressed little if any surface TCR-fl proteins, sequential anti-CD3e immunoprecipitations detected both CIC and donotypic TCR-7//~ complexes ( Fig. 3 B, right) . CIC surface complexes on fetal thymocytes could be isolated independently from donotypic TCR-3,/6 surface complexes by preclearing cell lysates with anti-TCR-/~ and anti-TCR-fl mAbs, followed by sequential immunoprecipitation with anti-CD3e mAb (Fig. 3 B, right) . Thus, CIC complexes including CD3AP are expressed on the surface of both TCR-SCID thymocytes and normal fetal thymocytes.
To further evaluate expression of CIC surface complexes on immature TCR-thymocytes, we examined the immature TCR-thymoma line BW5147. BW5147 cells did express surface CIC complexes consisting of CD3% e, and CD3AP (Fig. 4, top left) . The absence of CD3# in surface CIC compleaes on BW5147 cells reflects the absence of CD3/~ protein expression in the BW5147 subline used (22) . Importantly, because this BW5147 subline also fails to express TCR-fl, the TCR-cr chains remain unassembled within the endoplasmic reticulum and are not transported to the cell surface (data not shown). Indeed, significant amounts of intracellular TCR-c~ protein are present in BW5147 cells as demonstrated by protein immunoblots (Fig. 4, bottom) . De- spite the presence of a large intracelhlar pool of TCK-c~ chains, none of the TCR-cr became iodinated during the surface labeling procedure (Fig. 4, top left) . Taken together, these data demonstrate that 12SI-labeled CIC complexes were on the surface and were not internal protein complexes that had become 12SI-labeled at some point during the coupling reacExpression of Clonotype-independent CD3 Complexes on Immature Thymocytes tion, and are consistent with the detection of isolated CD3 complexes on another thymoma cell line (33) . Interestingly, even though we detected CIC complexes on BW5147 thymoma cells, we could not detect CIC complexes on the mature T cell hybridoma 2B4 that had been generated by fusion of a mature T cell with BW5147 thymoma cells (Fig. 4, top  right) . Thus, CIC complexes are expressed by an immature TCR-thymoma cell line but not expressed by a mature TCR + T cell hybridoma, mimicking the differential in vivo appearance of CIC complexes on immature thymocytes but not mature T cells.
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Discussion
The present results demonstrate that immature thymocytes, but not mature T calls, express CD3 proteins independently of the clonotypic TCR complexes. CIC complexes consist primarily of CD33,e and secondarily of CD36e heterodimers that are both physically and biochemically distinct from the CD3 chains that are part of clonotypic TCR complexes. In addition to CD3%6, and E proteins, CIC complexes are associated with an unknown surface protein termed CD3AP. CIC complexes may also contain other components that have not yet been identified. However, it is dear that CIC complexes are devoid of TCR-~ chains and so are distinct from TCR-B-X dimeric complem~s that have recently been described on immature thymocytes (7, 34) .
The biochemical characterization of CIC complexes that are expressed on the surface of immature thymocytes required the direct analysis of surface-labeled membrane proteins. Previous attempts using metabolic labeling to analyze the structure of surface TCR complexes in immature thymocytes must necessarily be uninformative as metabolic labeling identifies newly synthesized proteins that may or may not be eventually expressed on the cell surface (10) . This is a particular limitation of metabolic labeling experiments for examination of partial TCR complexes (10) that are largely, if not completely, retained intracellularly and not transported to the cell surface (1) . In the present study, we exclusively used surface labeling procedures to identify CIC complexes; nevertheless, the observed immaturity of their N-linked glycans suggested that they had not been processed by glycosidases resident in the Golgi apparatus (31, 32) and so might not really have been expressed on the cell surface. Consequently, it was important to exclude the possibility that internal protein complexes had been artefactually labeled during the surface hbeling reaction. In fact, we verified that the surface labeling was selective for cell surface proteins by looking for labeling of proteins known to be exclusively internal. No labeling of ribophorin I, ribophorin II, tubulin, or p56 Id~ was observed in CD4+CD8 + thymocytes, nor did we observe any labeling of the abundant internal TCK-c~ chains expressed by BW5147 thymoma cells. Finally, we directly demonstrated by flow cytometry the presence of low levels of CD3e expressed on the surface of SCID tbymocytes. It is important to emphasize that a precedent exists for expression by immature thymocytes of proteins bearing incompletely processed N-linked glycans. For example, TCK-/~ chains existing as TCK-B-X heterodimers on the surface of immature tbymocytes possess incompletely processed N-linked glycans (7, 34) . The molecular explanation for this incomplete processing of sugars is unclear, but may be related to an inability of immature thymocytes to efficiently retain incompletely assembled TCK complexes within the endoplasmic reticulum.
Identification of CIC complexes on immature TCR-thymocytes provides a structural basis for signaling in early thymocytes independently of clonotypic TCR complexes and provides a molecular basis for studies indicating functional effects of anti-CD3e mAb on early thymocyte development (11) (12) (13) . It is undear why CIC complexes consist overwhelmingly of CD3ye, rather than CD3~e, compka~s, but the predominance of CD3"ye complexes has also been observed in RAG-1-thymocytes (12) . The present results demonstrate that TCRearly tbymocytes express on their surfaces CIC complexes composed of proteins with the capability of transducing intracellular signals upon ligation by anti-CD3e mAb (35) . Thus, we think that CIC complexes are responsible for the ability of anti-CD3e stimulation to promote the differentiation of CD4-CD8-TCR-SCID and RAG-l-thymocytes into CD4+CD8 + cells (11, 12) . In addition, we think that CIC complexes on early TCR-tbymocytes might play a role in inducing maturation of the thymic microenvironment (36 
